相关实验视频
Updated: May 16, 2025
08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
930
在 Vitiligo 与 无形性皮肤炎 相关的 Upadacitinib 单疗法: 用一块石头杀死两只鸟
Lina Maria Magnanimi1,2, Andrea De Berardinis1,2, Maria Esposito1,2
1Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Case reports in dermatology
|April 2, 2025
概括
一种JAK1抑制剂,upadacitinib,在一个病人身上有效治疗了亚托皮炎 (AD) 和白风. 这表明Janus激酶 (JAK) 信号抑制是这些相关疾病的有前途的治疗策略.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亚托匹性皮肤炎 (AD) 患者患有白风的风险增加.
- 共享的病原遗传途径,包括Janus激酶/信号转换器和转录激活器 (JAK/STAT) 信号传输,链接AD和白风.
- 雅克抑制剂代表了白风的潜在治疗途径.
研究的目的:
- 评估JAK1抑制剂在治疗同时存在的亚托皮性皮炎和白病中的疗效.
- 探索JAK/STAT信号在两种疾病的发病过程中的作用.
主要方法:
- 一个25岁女性的案例研究,她有阿尔茨海默氏症和白风的病史.
- 在医疗和实验室评估后,每天服用15毫克的阿帕达西提尼布治疗.
- 监测AD和白风的进展和缓解.
主要成果:
- 乌帕达西替尼治疗导致阿尔茨海默病的逐步改善,在第16周实现了临床缓解.
- 与此同时,白风显著改善,在第28周几乎完全缓解.
- 这位患者经历了阿尔茨海默病和白风的缓解,并接受了上达西提尼布单一治疗.
结论:
- 用upadacitinib抑制JAK 1信号传递对阿尔茨海默病和白风患者具有治疗效益.
- 这一案例支持了JAK抑制剂作为治疗选择的实用性,用于管理同时存在的AD和白风.
相关概念视频
01:27Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
01:30Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
103
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
103